Ricardo Perdigão Henriques, PhD

Ricardo Perdigão Henriques, PhD is the Co-Founder and Managing Partner of Biovance Capital, a new venture capital firm focused on early-stage biotech investments.13 Here are some key details about his background and role:

Professional Experience

Ricardo is a Harvard and MIT-educated scientist who transitioned into venture capital and entrepreneurship.24 He has over 18 years of experience in the life sciences sector, spanning biomedical research, pharmaceutical business development, and venture capital in both the USA and Portugal.2

Current Role

As Managing Partner at Biovance Capital, Ricardo leads the identification of new investment opportunities and manages the firm's portfolio companies.3 He played a crucial role in establishing Biovance Capital Fund I, which recently announced its first closing at €51 million.1

Educational Background

• PhD in Molecular Oncology
• BSc in Biochemistry
• Educated at prestigious institutions including Harvard Medical School and MIT24

Prior Experience

Before co-founding Biovance Capital, Ricardo served as the CEO of Bionova Capital from 2019 to 2024.2 His diverse background includes publications in high-ranking scientific journals such as the Journal of Clinical Investigation and Oncogene.2

Vision and Impact

Ricardo is committed to developing Portugal's biomedical ecosystem and supporting innovative biotech companies across Europe, with a special focus on Southern Europe.1 His leadership at Biovance Capital aims to provide crucial capital and support for the development of novel transformational therapies addressing unmet medical needs.1